Comprehensive molecular characterization of gastric adenocarcinoma
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Gastric cancer is a leading cause of cancer deaths, but analysis of its molecular and clinical characteristics has been complicated by histological and aetiological heterogeneity. Here we describe a comprehensive molecular evaluation of 295 primary gastric adenocarcinomas as part of The Cancer Genome Atlas (TCGA) project. We propose a molecular classification dividing gastric cancer into four subtypes: tumours positive for Epstein–Barr virus, which display recurrent PIK3CA mutations, extreme DNA hypermethylation, and amplification of JAK2, CD274 (also known as PD-L1) and PDCD1LG2 (also known as PD-L2); microsatellite unstable tumours, which show elevated mutation rates, including mutations of genes encoding targetable oncogenic signalling proteins; genomically stable tumours, which are enriched for the diffuse histological variant and mutations of RHOA or fusions involving RHO-family GTPase-activating proteins; and tumours with chromosomal instability, which show marked aneuploidy and focal amplification of receptor tyrosine kinases. Identification of these subtypes provides a roadmap for patient stratification and trials of targeted therapies. The Cancer Genome Atlas reports on molecular evaluation of 295 primary gastric adenocarcinomas and proposes a new classification of gastric cancers into 4 subtypes, which should help with clinical assessment and trials of targeted therapies. This contribution from The Cancer Genome Atlas (TCGA) project describes the molecular evaluation of 295 primary gastric adenocarcinomas. Based on the results, the authors propose a novel classification separating gastric cancers into four subtypes according to: Epstein–Barr virus positive status, microsatellite instability, chromosomal instability or genomic stability. Given the histologic and etiologic heterogeneity of gastric cancer identification of these subtypes, using a schema that can readily be applied to patient samples should help with patient stratification and trials of targeted therapies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Many of the miRNAs were also reported by a recent systems biology paper from TCGA in 2014 [34].”
From Bioinformatic Interrogation of 5p-arm and 3p-arm Specific miRNA Expression Using TCGA Datasets (2015) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The fusion of this evidence has prompted TCGA and the Asian Cancer Research Group (ACRG) to propose several molecular classifications [77,78].”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [77]
The cited source says what the claim attributes to it.
In the citing paper
“The TP53/APC double knockout (DKO) organoid line was established in our previous studies by sequentially disrupting TP53 and APC37, two common oncogenic loci in gastric adenocarcinoma38,39, from non-neoplastic human gastric organoids (Fig. S1A).”
From Large-scale CRISPR screening in primary human 3D gastric organoids enables comprehensive dissection of gene-drug interactions (2025) · cites this paper as [38]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Fusobacterium spp. is important in the development and progression of gastrointestinal tumors1,19,34,35”
From RETRACTED ARTICLE: Microbiome analyses of blood and tissues suggest cancer diagnostic approach (2020) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
Self-citationLAURÉN, P. (1965) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/apm.1965.64.1.31 · Cited by 6,133
Integrated genomic characterization of endometrial carcinoma
The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Self-citationWHO Classification of Tumours of the Digestive System
Bosman, F. T. (2010) · Medical Entomology and Zoology · Cited by 5,041
Cell Migration: Integrating Signals from Front to Back
Ridley, A. J., Schwartz, M. A., Burridge, K., Firtel, R. A., Ginsberg, M. H., Borisy, G., Parsons, J. T., & Horwitz, A. R. (2003) · Science · doi:10.1126/science.1092053 · Cited by 4,978
Helicobacter pylori Infection and the Development of Gastric Cancer
Uemura, N., Okamoto, S., Yamamoto, S., Matsumura, N., Yamaguchi, S., Yamakido, M., Taniyama, K., Sasaki, N., & Schlemper, R. J. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa001999 · Cited by 4,465
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278
Fuchs, C. S., Tomasek, J., Yong, C. J., Dumitru, F., Passalacqua, R., Goswami, C., Safran, H., dos Santos, L. V., Aprile, G., Ferry, D. R., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61719-5 · Cited by 2,188
Research works printed but not linked: 2
- Ferlay, J. et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide. IARC CancerBase 11, http://globocan.iarc.fr, accessed on January 15, 2014 (2013)
- The Cancer Genome Atlas Network Comprehensive molecular characterization of human colon and rectal cancer. Nature 487, 330–337 (2012) · DOI · Paper page
Cited by
Items 901–1,000 of 1,024
Predicting cancer type from tumour DNA signatures
Soh, K. P., Szczurek, E., Sakoparnig, T., & Beerenwinkel, N. (2017) · Genome Medicine · doi:10.1186/s13073-017-0493-2 · Cited by 69
Premalignant lesions and gastric cancer: Current understanding
Koulis, A., Buckle, A. D., & Boussioutas, A. (2019) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v11.i9.665 · Cited by 73
Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer’s disease
Eteleeb, A. M., Novotny, B. C., Tarraga, C. S., Sohn, C., Dhungel, E., Brase, L., Nallapu, A., Buss, J., Farias, F., Bergmann, K., et al. (2024) · PLOS Biology · doi:10.1371/journal.pbio.3002607 · Cited by 64
Intratumoral Immune Response to Gastric Cancer Varies by Molecular and Histologic Subtype
Kim, T. S., da Silva, E. M., Coit, D. G., & Tang, L. H. (2019) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001253 · Cited by 73
Clustered protocadherins methylation alterations in cancer
Vega-Benedetti, A. F., Loi, E., Moi, L., Blois, S., Fadda, A., Antonelli, M., Arcella, A., Badiali, M., Giangaspero, F., Morra, I., et al. (2019) · Clinical Epigenetics · doi:10.1186/s13148-019-0695-0 · Cited by 80
Global progress and future prospects of early gastric cancer screening
Huang, Y., Shao, Y., Yu, X., Chen, C., Guo, J., & Ye, G. (2024) · Journal of Cancer · doi:10.7150/jca.95311 · Cited by 72
“MSI-H is the second most common type after CIN, which accounts for the majority of cases [152].”
BackgroundPlasmacytoid Urothelial Carcinoma of the Urinary Bladder
Fox, M. D., Xiao, L., Zhang, M., Kamat, A. M., Siefker-Radtke, A. O., Zhang, L., Dinney, C. P., Czerniak, B. A., & Guo, C. C. (2017) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqx029 · Cited by 65
Yamazawa, S., Ushiku, T., Shinozaki‐Ushiku, A., Hayashi, A., Iwasaki, A., Abé, H., Tagashira, A., Yamashita, H., Seto, Y., Aburatani, H., et al. (2017) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000869 · Cited by 67
Kawazoe, A., Shitara, K., Kuboki, Y., Bando, H., Kojima, T., Yoshino, T., Ohtsu, A., Ochiai, A., Togashi, Y., Nishikawa, H., et al. (2018) · Gastric Cancer · doi:10.1007/s10120-018-0843-9 · Cited by 65
Morihiro, T., Kuroda, S., Kanaya, N., Kakiuchi, Y., Kubota, T., Aoyama, K., Tanaka, T., Kikuchi, S., Nagasaka, T., Nishizaki, M., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41177-2 · Cited by 68
PD-L1 expression is associated with massive lymphocyte infiltration and histology in gastric cancer
Li, Z., Lai, Y., Sun, L. N., Zhang, X., Liu, R., Feng, G., Zhou, L., Jia, L., Huang, X., Kang, Q., et al. (2016) · Human Pathology · doi:10.1016/j.humpath.2016.05.012 · Cited by 63
Isoforms of the p53 Family and Gastric Cancer: A Ménage à Trois for an Unfinished Affair
Blanchet, A., Bourgmayer, A., Kurtz, J., Mellitzer, G., & Gaiddon, C. (2021) · Cancers · doi:10.3390/cancers13040916 · Cited by 72
Tabernero, J. M., Bang, Y., Cutsem, E. V., Fuchs, C. S., Janjigian, Y. Y., Bhagia, P., Li, K., Adelberg, D. E., & Qin, S. (2021) · Future Oncology · doi:10.2217/fon-2021-0176 · Cited by 65
The molecular biology of peritoneal metastatic disease
Bootsma, S., Bijlsma, M. F., & Vermeulen, L. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202215914 · Cited by 66
“This is in line with the association between the diffuse subtype and the formation of PM, since this subtype is strongly associated with RHOA and CDH1 mutations (Cancer Genome Atlas Research Network, 2014; Kakiuchi et al, 2014).”
ResultLuo, D. Y., Zhou, J., Ruan, S., Zhang, B., Zhu, H., Que, Y., Ying, S., Li, X., Hu, Y., & Song, Z. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07385-7 · Cited by 81
Choi, Y. Y., Noh, S. H., & Cheong, J. (2015) · Yonsei Medical Journal · doi:10.3349/ymj.2015.56.5.1177 · Cited by 69
Features of Gastric Carcinoma With Lymphoid Stroma Associated With Epstein-Barr Virus
Lim, H. K., Park, Y. S., Lee, J. H., Son, D. H., Ahn, J. Y., Choi, K., Kim, D. H., Choi, K. D., Song, H. J., Lee, G. H., et al. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.04.015 · Cited by 63
Bae, J., & Kim, E. H. (2016) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.15.068 · Cited by 65
Strong, M. J., Blanchard, E., Lin, Z. N., Morris, C. A., Baddoo, M., Taylor, C. M., Ware, M. L., & Flemington, E. K. (2016) · Acta Neuropathologica Communications · doi:10.1186/s40478-016-0338-z · Cited by 76
Wu, H., Hu, Y., Liu, X., Song, W., Gong, P., Zhang, K., Chen, Z., Zhou, M., Shen, X., Qian, Y., et al. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2017.06.021 · Cited by 65
Hewitt, L. C., Inam, I. Z., Saito, Y., Yoshikawa, T., Quaas, A., Hoelscher, A. H., Bollschweiler, E., Fazzi, G. E., Melotte, V., Langley, R. E., et al. (2018) · European Journal of Cancer · doi:10.1016/j.ejca.2018.02.014 · Cited by 72
Yang, L., Sun, Q., Jiang, M., Li, S., Zhang, J., Xu, Z., Guo, D., Gu, T., Wang, B., Xiao, L., et al. (2019) · The FASEB Journal · doi:10.1096/fj.201802531r · Cited by 70
Surgery Strategies for Gastric Cancer With Liver Metastasis
Luo, Z., Rong, Z., & Huang, C. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01353 · Cited by 79
Immune signatures correlate with L1 retrotransposition in gastrointestinal cancers
Jung, H., Choi, J. K., & Lee, E. A. (2018) · Genome Research · doi:10.1101/gr.231837.117 · Cited by 63
Immunotherapy for Gastric Cancer: Time for a Personalized Approach?
Dolcetti, R., Re, V. D., & Canzonieri, V. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19061602 · Cited by 65
Targeting Immune-Related Biological Processes in Solid Tumors: We do Need Biomarkers
Pagni, F., Guerini‐Rocco, E., Schultheis, A. M., Grazia, G., Rijavec, E., Ghidini, M., Lopez, G., Venetis, K., Croci, G. A., Malapelle, U., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215452 · Cited by 64
“MSI tumors, accounting for 22% of GCs, harbor high TMB and increased number of neoantigens [76].”
BackgroundCurrent prognostic and predictive biomarkers for gastrointestinal tumors in clinical practice
Fassan, M., Scarpa, A., Remo, A., Maglio, G. D., Troncone, G., Marchetti, A., Doglioni, C., Ingravallo, G., Perrone, G., Parente, P., et al. (2020) · Pathologica · doi:10.32074/1591-951x-158 · Cited by 68
Current status of immunotherapy for advanced gastric cancer
Kawazoe, A., Shitara, K., Boku, N., Yoshikawa, T., & Terashima, M. (2020) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyaa202 · Cited by 67
Nakano, H., Saito, M., Nakajima, S., Saito, K., Nakayama, Y., Kase, K., Yamada, L., Kanke, Y., Hanayama, H., Onozawa, H., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-81667-w · Cited by 76
Zhao, J. J., Ong, C. J., Srivastava, S., Chia, D. K. A., Ma, H., Huang, K. K., Sheng, T., Ramnarayanan, K., Ong, X., Tay, S. T., et al. (2024) · Gastroenterology · doi:10.1053/j.gastro.2024.08.007 · Cited by 81
Frequent involvement of chromatin remodeler alterations in gastric field cancerization
Takeshima, H., Niwa, T., Takahashi, T., Wakabayashi, M., Yamashita, S., Ando, T., 稲川, 悠., Taniguchi, H., Katai, H., Sugiyama, T., et al. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.11.038 · Cited by 62
Novel targets in the treatment of advanced gastric cancer: a perspective review
Fontana, E., & Smyth, E. C. (2016) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758834015616935 · Cited by 65
Rnd3 in Cancer: A Review of the Evidence for Tumor Promoter or Suppressor
Paysan, L., Piquet, L., Saltel, F., & Moreau, V. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0164 · Cited by 68
Prevete, N., Liotti, F., Illiano, A., Amoresano, A., Pucci, P., de Paulis, A., & Melillo, R. M. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1293213 · Cited by 61
Recent advances in understanding Epstein-Barr virus
Stanfield, B. A., & Luftig, M. A. (2017) · F1000Research · doi:10.12688/f1000research.10591.1 · Cited by 62
Huang, J., He, Y., McLeod, H. L., Xie, Y., Xiao, D., Hu, H., Chen, P., Shen, L., Zeng, S., Yin, X., et al. (2017) · BMC Cancer · doi:10.1186/s12885-017-3875-3 · Cited by 62
Hill, D. G., Yu, L., Gao, H., Balic, J. J., West, A. C., Oshima, H., McLeod, L., Oshima, M., Gallimore, A., D’Costa, K., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31298 · Cited by 64
Cao, L., Wang, S., Zhang, Y., Wong, K., Nakatsu, G., Wang, X., Wong, S. H., Ji, J., & Yu, J. Q. (2018) · Oncogene · doi:10.1038/s41388-018-0220-5 · Cited by 66
Lenouvel, D., González‐Moles, M. Á., Talbaoui, A., Ramos‐García, P., González‐Ruiz, L., Ruiz‐Ávila, I., & Montoya, J. A. G. (2019) · Oral Diseases · doi:10.1111/odi.13088 · Cited by 70
A pan-cancer analysis of prognostic genes
Anaya, J., Reon, B. J., Chen, W., Bekiranov, S., & Dutta, A. (2016) · PeerJ · doi:10.7717/peerj.1499 · Cited by 62
Dwyer, D., Kalman, J. L., Budde, M., Kambeitz, J. P., Ruef, A., Antonucci, L. A., Kambeitz‐Ilankovic, L., Hasan, A., Kondofersky, I., Anderson‐Schmidt, H., et al. (2020) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2019.4910 · Cited by 73
Epstein-Barr virus BART microRNAs in EBV- associated Hodgkin lymphoma and gastric cancer
Re, V. D., Caggiari, L., Zorzi, M. D., Fanotto, V., Miolo, G., Puglisi, F., Cannizzaro, R., Canzonieri, V., Steffan, A., Farruggia, P., et al. (2020) · Infectious Agents and Cancer · doi:10.1186/s13027-020-00307-6 · Cited by 68
Song, S., Chen, Q., Li, Y., Lei, G., Scott, A. W., Huo, L., Li, C. Y., Estrella, J. S., Correa, A. M., Pizzi, M. P., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-321175 · Cited by 65
New molecular classification of gastric adenocarcinoma proposed by The Cancer Genome Atlas
Razzak, M. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.138 · Cited by 61
Qamra, A., Xing, M., Padmanabhan, N., Kwok, J. J. T., Zhang, S., Xu, C., Leong, Y. S., Lim, A. P. L., Tang, Q., Ooi, W. F., et al. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-16-1022 · Cited by 68
Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients
Schumacher, S. E., Shim, B. Y., Corso, G., Ryu, M., Kang, Y., Roviello, F., Saksena, G., Peng, S., Shivdasani, R. A., Bass, A. J., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176045 · Cited by 63
FOXM1 functions collaboratively with PLAU to promote gastric cancer progression
Ai, C., Zhang, J., Lian, S., Ma, J., Győrffy, B., Qian, Z., Han, Y. K., & Feng, Q. F. (2019) · Journal of Cancer · doi:10.7150/jca.37323 · Cited by 66
“Because of the high recurrence rate and poor prognosis of GC, there still one half of the patients suffer surgery but with no changes in long term survival[55].”
BackgroundUniversal encoding of pan-cancer histology by deep texture representations
Komura, D., Kawabe, A., Fukuta, K., Sano, K., Umezaki, T., Koda, H., Suzuki, R., Tominaga, K., Ochi, M., Konishi, H., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110424 · Cited by 60
Fassan, M., Kuwata, T., Matkowskyj, K. A., Röcken, C., & Rüschoff, J. (2024) · Modern Pathology · doi:10.1016/j.modpat.2024.100589 · Cited by 72
Ma, H., Srivastava, S., Ho, S. W. T., Xu, C., Lian, B. S. X., Ong, X., Tay, S. T., Sheng, T., Lum, H. Y. J., Ghani, S. A. B. A., et al. (2025) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0605 · Cited by 78
“Clinical information of the gastric cancer samples, including tumor stage, HER2, EBV status, DNA Mismatch Re-pair (MMR), survival, gender, age, and other related information is presented in Supplementary Table S2.”
InfluentialKim, H. S., Shin, S., Beom, S., Jung, M., Choi, Y. Y., Son, T., Kim, H., Cheong, J., Hyung, W. J., Noh, S. H., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10115 · Cited by 68
Hu, L., Liang, S., Chen, H., Lv, T., Wu, J., Chen, D., Wu, M. C., Sun, S., Zhang, H., You, H., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617816114 · Cited by 67
The significance of a nineteenth century definition in the era of genomics: linitis plastica
Agnes, A., Estrella, J. S., & Badgwell, B. D. (2017) · World Journal of Surgical Oncology · doi:10.1186/s12957-017-1187-3 · Cited by 77
Ma, L., Feng, F., Dong, L., Zhang, Z., Duan, M., Liu, L., Shi, J.-Y., Yang, L., Wang, Z., Zhang, S., et al. (2018) · Theranostics · doi:10.7150/thno.28742 · Cited by 67
PD-L1 and immune infiltrates are differentially expressed in distinct subgroups of gastric cancer
Angell, H. K., Lee, J., Kim, K., Kim, K. E., Kim, S. T., Park, S. H., Kang, W. K., Sharpe, A. D., Ogden, J., Davenport, A., et al. (2018) · OncoImmunology · doi:10.1080/2162402x.2018.1544442 · Cited by 67
RhoGTPases – A novel link between cytoskeleton organization and cisplatin resistance
Mokady, D., & Meiri, D. (2015) · Drug Resistance Updates · doi:10.1016/j.drup.2015.01.001 · Cited by 65
Tuna, M., Machado, A. S., & Călin, G. A. (2015) · Genes Chromosomes and Cancer · doi:10.1002/gcc.22332 · Cited by 67
Liao, P., Li, W., Liu, R., Teer, J. K., Xu, B., Zhang, W., Li, X., McLeod, H. L., & He, Y. (2018) · OncoTargets and Therapy · doi:10.2147/ott.s173934 · Cited by 65
“5,6 But the cause of GC remains to be further elucidated.”
Wang, X., Zeng, Z., Ye, X., Sun, J., Zhang, Z.-M., & Kang, W. (2019) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v12.i1.37 · Cited by 66
Jiang, A., Luo, P., Chen, M., Fang, Y., Liu, B., Wu, Z., Qu, L., Wang, A., Wang, L., & Cai, C. (2022) · Cell & Bioscience · doi:10.1186/s13578-022-00948-7 · Cited by 67
Zolbetuximab for Claudin18.2-positive gastric or gastroesophageal junction cancer
Kubota, Y., & Shitara, K. (2024) · Therapeutic Advances in Medical Oncology · doi:10.1177/17588359231217967 · Cited by 72
Ying, J., Xu, Q., Liu, B., Zhang, G., Chen, L., & Pan, H. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s88592 · Cited by 64
Sepulveda, J. L., Gutiérrez-Pajares, J. L., Luna, A. M., Yao, Y., Tobias, J. W., Thomas, S. M., Woo, Y., Giorgi, F. M., Komissarova, E. V., Califano, A., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2015.144 · Cited by 68
Molecular alterations in gastric cancer with special reference to the early-onset subtype
Skierucha, M., Milne, A. N., Offerhaus, G. J. A., Polkowski, W. P., Maciejewski, R., & Sitarz, R. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i8.2460 · Cited by 72
Notch as a Driver of Gastric Epithelial Cell Proliferation
Demitrack, E. S., & Samuelson, L. C. (2017) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.01.012 · Cited by 63
Clinical significance of tumor-infiltrating lymphocytes for gastric cancer in the era of immunology
Kang, B. W., Kim, J. G., Lee, I. H., Bae, H. I., & Seo, A. N. (2017) · World Journal of Gastrointestinal Oncology · doi:10.4251/wjgo.v9.i7.293 · Cited by 60
Formalin-fixed paraffin-embedded sample conditions for deep next generation sequencing
Nagahashi, M., Shimada, Y., Ichikawa, H., Nakagawa, S., Sato, N., Kaneko, K., Homma, K., Kawasaki, T., Kodama, K., Lyle, S. R., et al. (2017) · Journal of Surgical Research · doi:10.1016/j.jss.2017.06.077 · Cited by 60
Jeusset, L. M., & McManus, K. J. (2017) · Cancers · doi:10.3390/cancers9120167 · Cited by 66
Battaglin, F., Naseem, M., Puccini, A., & Lenz, H. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0594-z · Cited by 67
Surgical treatment of gastric cancer: a 10-year experience in a high-volume university hospital
Ramos, M. F. K. P., Pereira, M. A., Yagi, O. K., Dias, A. R., Charruf, A. Z., de Oliveira, R. J., Zaidan, E. P., Zilberstein, B., Ribeiro, U., & Cecconello, I. (2018) · Clinics · doi:10.6061/clinics/2018/e543s · Cited by 60
Heterogeneity and dynamics of active Kras-induced dysplastic lineages from mouse corpus stomach
Min, J., Vega, P. N., Engevik, A. C., Williams, J. A., Yang, Q., Patterson, L. M., Simmons, A. J., Bliton, R. J., Betts, J. W., Lau, K. S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13479-6 · Cited by 65
Function and diagnostic value of Anosmin‐1 in gastric cancer progression
Kanda, M., Shimizu, D., Fujii, T., Sueoka, S., Tanaka, Y., Ezaka, K., Takami, H., Tanaka, H., Hashimoto, R., Iwata, N., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29803 · Cited by 59
Molecular Characterization of Gastric Carcinoma: Therapeutic Implications for Biomarkers and Targets
Fonkoua, L. A. K., & Yee, N. S. (2018) · Biomedicines · doi:10.3390/biomedicines6010032 · Cited by 69
MTHFR C677T and A1298C Polymorphisms in Breast Cancer, Gliomas and Gastric Cancer: A Review
Petrone, I., Bernardo, P. S., dos Santos, E. C., & Abdelhay, E. S. F. W. (2021) · Genes · doi:10.3390/genes12040587 · Cited by 67
A Global Perspective on Gastric Cancer Screening: Which Concepts Are Feasible, and When?
Januszewicz, W., Turkot, M. H., Malfertheiner, P., & Reguła, J. (2023) · Cancers · doi:10.3390/cancers15030664 · Cited by 69
“Furthermore, molecular profiling has led to the identification of four molecular subtypes of GC: (i) tumors positive for Epstein–Barr virus (EBV), (ii) a microsatellite-unstable (MSI) subtype, (iii) genomically stable (GS) tumors, and (iv) tumors with chromosomal instability (CIN) [6].”
BackgroundMultiancestry genomic and transcriptomic analysis of gastric cancer
Totoki, Y., Saito-Adachi, M., Shiraishi, Y., Komura, D., Nakamura, H. K., Suzuki, A., Tatsuno, K., Rokutan, H., Hama, N., Yamamoto, S., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01333-x · Cited by 71
Wang, Z., Wang, Q., Chen, C., Zhao, X., Wang, H., Xu, L., Fu, Y. S., Huang, G. S., Li, M., Xu, J., et al. (2023) · Gut · doi:10.1136/gutjnl-2022-328408 · Cited by 63
The role of the gut microbiota in gastric cancer: the immunoregulation and immunotherapy
Wang, M., Yang, G., Tian, Y., Zhang, Q., Liu, Z., & Xin, Y. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1183331 · Cited by 74
Sue, S., Shibata, W., & Maeda, S. (2015) · BioMed Research International · doi:10.1155/2015/737621 · Cited by 61
RCAN1-4 is a thyroid cancer growth and metastasis suppressor
Wang, C., Saji, M., Justiniano, S. E., Yusof, A. M., Zhang, X., Yu, L., Fernández, S., Wakely, P. E., Perle, K. L., Nakanishi, H., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.90651 · Cited by 59
Integrative Analysis of Omics Big Data
Yu, X., & Zeng, T. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-7717-8_7 · Cited by 68
RHOA in Gastric Cancer: Functional Roles and Therapeutic Potential
Nam, S., Kim, J. H., & Lee, D. H. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00438 · Cited by 67
Thirty years of Epstein-Barr virus-associated gastric carcinoma
Fukayama, M., Abé, H., Kunita, A., Shinozaki‐Ushiku, A., Matsusaka, K., Ushiku, T., & Kaneda, A. (2019) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-019-02724-4 · Cited by 59
Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities
Canale, M., Gardini, A. C., Ulivi, P., Arechederra, M., Berasain, C., Lollini, P., Fernández‐Barrena, M. G., & Avila, M. A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155500 · Cited by 68
Qiu, M.-Z., Wang, C., Wu, Z., Zhao, Q., Zhao, Z., Huang, C.-Y., Wu, W., Yang, L.-Q., Zhou, Z.-W., Zheng, Y., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01622-1 · Cited by 58
“EBV (+) GC is a distinct subset identified by The Cancer Genome Atlas (TCGA) Research Network.(8) In 2018, Panda A et al.”
BackgroundEndoplasmic reticulum proteostasis control and gastric cancer
Wang, Y., Wang, K., Jin, Y., & Sheng, X. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.01.034 · Cited by 63
Liu, H., Wu, N., Zhang, Z., Zhong, X., Zhang, H., Guo, H., Nie, Y., & Liu, Y. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00005 · Cited by 62
Resolution of Gastric Cancer-Promoting Inflammation: A Novel Strategy for Anti-cancer Therapy
Piazuelo, M. B., Riechelmann, R. P., Wilson, K. T., & Algood, H. M. S. (2019) · Current topics in microbiology and immunology · doi:10.1007/978-3-030-15138-6_13 · Cited by 69
The diffuse-type gastric cancer epidemiology enigma
de Assumpção, P. P., Barra, W. F., Ishak, G., Coelho, L. G. V., Coimbra, F. J. F., Freitas, H., Dias‐Neto, E., Camargo, M. C., & Szklo, M. (2020) · BMC Gastroenterology · doi:10.1186/s12876-020-01354-4 · Cited by 73
Non-coding RNAs in gastric cancer
Xie, S., Chang, Y., Jin, H., Yang, F., Xu, Y., Yan, X., Lin, A., Shu, Q., & Zhou, T. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.06.022 · Cited by 72
Morphologic and molecular analysis of early‐onset gastric cancer
Setia, N., Wang, C. X., Lager, A. M., Maron, S. B., Shroff, S. G., Arndt, N., Peterson, B. F., Kupfer, S. S., Ma, C., Misdraji, J., et al. (2020) · Cancer · doi:10.1002/cncr.33213 · Cited by 58
Machine learning analysis of TCGA cancer data
Liñares-Blanco, J., Pazos, A., & Fernandez-Lozano, C. (2021) · PeerJ Computer Science · doi:10.7717/peerj-cs.584 · Cited by 72
Bian, S., Wang, Y., Zhou, Y., Wang, W., Guo, L., Wen, L., Fu, W., Zhou, X., & Tang, F. (2023) · National Science Review · doi:10.1093/nsr/nwad094 · Cited by 66
Liu, C., Tang, H., Hu, N., & Li, T. (2023) · Cancer Cell International · doi:10.1186/s12935-023-03074-7 · Cited by 69
“In addition, gastric cancer can be classified into four subtypes based on the TCGA network, including Epstein–Barr virus (EBV)-positive, microsatellite-unstable/instability (MSI), genomically stable (GS), and chromosomal instability (CIN) [120].”
BackgroundHuang, G., Cui, F., Yu, F., Lu, H., Zhang, M., Tang, H., & Peng, Z. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.04.013 · Cited by 58
RHOA mutation in diffuse-type gastric cancer: a comparative clinicopathology analysis of 87 cases
Ushiku, T., Ishikawa, S., Kakiuchi, M., Tanaka, A., Katoh, H., Aburatani, H., Lauwers, G. Y., & Fukayama, M. (2015) · Gastric Cancer · doi:10.1007/s10120-015-0493-0 · Cited by 58
Chromosomal Instability in Gastric Cancer Biology
Maleki, S. S., & Röcken, C. (2017) · Neoplasia · doi:10.1016/j.neo.2017.02.012 · Cited by 77
Gullo, I., Oliveira, P., Athelogou, M., Gonçalves, G., Pinto, M. L., Carvalho, J., Valente, A., Pinheiro, H. C., Andrade, S., Almeida, G. M., et al. (2018) · Gastric Cancer · doi:10.1007/s10120-018-0836-8 · Cited by 65
Haag, G. M., Czink, E., Ahadova, A., Schmidt, T., Sisic, L., Blank, S., Heger, U., Apostolidis, L., Berger, A. K., Springfeld, C., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.32030 · Cited by 62
Sundar, R., Huang, K. K., Qamra, A., Kim, K.-M., Kim, S. T., Kang, W. K., Tan, A., Lee, J., & Tan, P. B. O. (2019) · Annals of Oncology · doi:10.1093/annonc/mdy550 · Cited by 61
Metadata
- Authors
- The Cancer Genome Atlas Research Network
- Venue
- Nature
- Published
- 2014-07-23
- Volume
- 513
- Issue
- 7517
- Pages
- 202-209
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4170219
- OpenAlex
- W2126547130
- Cited by
- 6,498
- References
- 43
- Citations by year
- 2026: 455 · 2025: 481 · 2024: 569 · 2023: 637 · 2022: 620 · 2021: 737 · 2020: 653 · 2019: 554 · 2018: 560 · 2017: 490 · 2016: 398 · 2015: 297 · 2014: 41
- FWCI
- 327.21
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- creativecommons.org/licenses/by-nc-sa/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-sa/3.0/ (vor)
- Locations
- Nature (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-sa)
- KUMeL Repository (Keimyung University) (submittedVersion, cc-by-nc-nd)
- Scholarworks@UNIST (Ulsan National Institute of Science and Technology) (submittedVersion)
- Funders
- National Institutes of Health
- National Human Genome Research Institute (U54HG003067, R01HG007069, U54HG003079, U54HG003273, R01HG005690)
- National Cancer Institute (P30CA16672, K08CA134931, P50CA098258, U24CA143882, P01CA028842, R01CA180006, U24CA143843, U24CA143840, U24CA143858, U24CA126543, U24CA144025, U24CA143866, U24CA143883, U24CA143845, U24CA180951, U24CA143867, U24CA143848, U24CA143799, U24CA143835, K99CA166729, P30CA008748, P30CA016672, P30CA006973)
- Topics
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal Tumor Research and Treatment
- Keywords
- gastric adenocarcinoma, molecular classification, Epstein-Barr virus, PIK3CA mutation, DNA hypermethylation, PD-L1, PD-L2, microsatellite instability, chromosomal instability, genome stability, RHOA mutations, aneuploidy, targeted therapy, patient stratification
- MeSH terms
- Adenocarcinoma, Herpesvirus 4, Human, Female, Humans, Male, Mutation, Stomach Neoplasms, Genome, Human, Gene Expression Regulation, Neoplastic, Proteome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.